{
    "SPADE_N_15008": {
        "Sequence Information": {
            "Peptide Name": "Brevibacillin",
            "Sequence": "XLXIIVKVVKYL",
            "Sequence Length": 12,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Brevibacillus laterosporus OSY-I1",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Isolation and Structural Elucidation of Brevibacillin, an Antimicrobial Lipopeptide from Brevibacillus laterosporus That Combats Drug-Resistant Gram-Positive Bacteria.",
                    "Pubmed ID": "26921428",
                    "Reference": "Appl Environ Microbiol. 2016;82:2763-2772",
                    "Author": "Yang X, Huang E, Yuan C, Zhang L, Yousef AE",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26921428"
                },
                {
                    "Title": "Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity.",
                    "Pubmed ID": "34220785",
                    "Reference": "Front Microbiol. 2021;12:693725",
                    "Author": "Zhao X, Wang X, Shukla R, Kumar R, Weingarth M, Breukink E, Kuipers OP",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34220785"
                }
            ],
            "SPADE ID": "SPADE_N_15008",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_05353",
                    "Similarity": 1.0,
                    "Sequence": "WYKKIRLII"
                },
                {
                    "SPADE_ID": "SPADE_UN_17542",
                    "Similarity": 1.0,
                    "Sequence": "LIIVKVVKYL"
                },
                {
                    "SPADE_ID": "SPADE_N_08685",
                    "Similarity": 1.0,
                    "Sequence": "VKYLEFKSESIKQVK"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=25.1±0.1 µg/ml",
            "Target Organism": "Alicyclobacillus acidoterrestris ATCC 49025(MIC=0.5-1.0µg/ml),Bacillus cereus ATCC 11778(MIC=2-4µg/ml),Bacillus cereus ATCC 14579(MIC=1µg/ml),Clostridioides difficile(MIC=4-8µg/ml),Enterococcus faecalis ATCC 29212(MIC=2µg/ml),Enterococcus faecalis ATCC 51299(MIC=4-8µg/ml),Lactiplantibacillus plantarum ATCC 8014(MIC=1µg/ml),Lactococcus lactis ATCC 11454(MIC=2µg/ml),Listeria innocua ATCC 33090(MIC=1-2µg/ml),Listeria monocytogenes Scot A(MIC=1µg/ml),Staphylococcus aureus ATCC 6538(MIC=1-2µg/ml),Escherichia coli K-12(MIC=>32µg/ml),Escherichia coli O157:H7(MIC=32µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>32µg/ml),Salmonella enterica subsp. enterica serovar Typhimurium DT104(MIC=>32µg/ml),Staphylococcus aureus ATCC 15975(MIC=2µg/ml),Enterococcus faecium LMG 16003(MIC=2µg/ml),Enterococcus faecalis LMG 16216(MIC=2µg/ml),Bacillus cereus ATCC 14579(MIC=1µg/ml),Acinetobacter baumannii ATCC 17978(MIC=32µg/ml),Escherichia coli ATCC 25922(MIC=32µg/ml),Pseudomonas aeruginosa LMG 6395(MIC=64µg/ml),Klebsiella pneumoniae LMG 20218(MIC=32µg/ml),Human hepatocellular carcinoma HepG2(50-60% Cytotoxicity=5.21±0.01µg/ml)"
        }
    }
}